These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34112886)

  • 1. HLA-B27 is associated with reduced disease activity in axial spondyloarthritis.
    Rosenbaum JT; Weisman MH; Hamilton H; Shafer C; Aslanyan E; Howard RA; Ogle K; Reveille JD; Winthrop KL; Choi D
    Sci Rep; 2021 Jun; 11(1):12331. PubMed ID: 34112886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
    Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
    J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
    van Lunteren M; van der Heijde D; Sepriano A; Berg IJ; Dougados M; Gossec L; Jacobsson L; Ramonda R; Rudwaleit M; Sieper J; Landewé R; van Gaalen FA
    Rheumatology (Oxford); 2019 Sep; 58(9):1649-1654. PubMed ID: 30938446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Referral strategies for early diagnosis of axial spondyloarthritis.
    Rudwaleit M; Sieper J
    Nat Rev Rheumatol; 2012 Apr; 8(5):262-8. PubMed ID: 22487797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.
    Baraliakos X; Baerlecken N; Witte T; Heldmann F; Braun J
    Ann Rheum Dis; 2014 Jun; 73(6):1079-82. PubMed ID: 23644552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab.
    Otsuka A; Morita M; Yamada H
    J Orthop Sci; 2015 Nov; 20(6):1070-7. PubMed ID: 26245191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of HLA-B27 in Argentinian Axial Spondyloarthritis Patients.
    García-Salinas R; Ruta S; Chichande JT; Magri S
    J Clin Rheumatol; 2022 Mar; 28(2):e619-e622. PubMed ID: 34145202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status?
    Coates LC; Baraliakos X; Blanco FJ; Blanco-Morales EA; Braun J; Chandran V; Fernandez-Sueiro JL; FitzGerald O; Gallagher P; Gladman DD; Gubar E; Korotaeva T; Loginova E; Lubrano E; Mulero J; Pinto-Tasende J; Queiro R; Sanz Sanz J; Szentpetery A; Helliwell PS
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):856-860. PubMed ID: 32100954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry.
    Fröhlich F; Micheroli R; Hebeisen M; Kissling S; Bürki K; Exer P; Bräm R; Niedermann K; Möller B; Nissen MJ; Kyburz D; Andor M; Distler O; Scherer A; Ciurea A
    Clin Rheumatol; 2023 May; 42(5):1267-1274. PubMed ID: 36574181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27.
    Braun A; Gnann H; Saracbasi E; Grifka J; Kiltz U; Letschert K; Braun J
    Rheumatology (Oxford); 2013 Aug; 52(8):1418-24. PubMed ID: 23559574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease.
    Cauli A; Dessole G; Fiorillo MT; Vacca A; Mameli A; Bitti P; Passiu G; Sorrentino R; Mathieu A
    Rheumatology (Oxford); 2002 Dec; 41(12):1375-9. PubMed ID: 12468816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
    Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
    Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sponyloarthritis features forecasting the presence of HLA-B27 or sacroiliitis on magnetic resonance imaging in patients with suspected axial spondyloarthritis: results from a cross-sectional study in the ESPeranza Cohort.
    Navarro-Compán V; de Miguel E; van der Heijde D; Landewé R; Almodóvar R; Montilla C; Beltrán E; Zarco P
    Arthritis Res Ther; 2015 Sep; 17(1):265. PubMed ID: 26395086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
    Ez-Zaitouni Z; Hilkens A; Gossec L; Berg IJ; Landewé R; Ramonda R; Dougados M; van der Heijde D; van Gaalen F
    Arthritis Res Ther; 2017 May; 19(1):118. PubMed ID: 28569222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE)].
    da Costa IP; Bortoluzzo AB; Gonçalves CR; da Silva JA; Ximenes AC; Bértolo MB; Ribeiro SL; Keiserman M; Menin R; Skare TL; Carneiro S; Azevedo VF; Vieira WP; Albuquerque EN; Bianchi WA; Bonfiglioli R; Campanholo C; Carvalho HM; Duarte AL; Kohem CL; Leite NH; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
    Rev Bras Reumatol; 2015; 55(1):48-54. PubMed ID: 25542672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study.
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Ann Rheum Dis; 2012 Jul; 71(7):1207-11. PubMed ID: 22523430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia.
    Omair MA; AlDuraibi FK; Bedaiwi MK; Abdulaziz S; Husain W; El Dessougi M; Alhumaidan H; Al Khabbaz HJ; Alahmadi I; Omair MA; Al Saleh S; Alismael K; Al Awwami M
    Clin Rheumatol; 2017 Jul; 36(7):1537-1543. PubMed ID: 28456926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.
    Danve A; Reddy A; Vakil-Gilani K; Garg N; Dinno A; Deodhar A
    Clin Rheumatol; 2015 Jan; 34(1):117-24. PubMed ID: 25421013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.